Medical Communications
Cambridge’s Experimental Cancer Medicine Centre to receive funding for clinical trials
January 18, 2023 Medical Communications
The Experimental Cancer Medicine Centre (ECMC) in Cambridge is one of a selection of organisations to receive a share of …
UCL to begin new trial to assess cough medicine’s impact on Parkinson’s disease
January 17, 2023 Medical Communications
Researchers led by a team at University College London (UCL) have began researching the impacts of ambroxol, a common ingredient …
Thermo Fisher to become founding sponsor of Momentum Labs
January 17, 2023 Medical Communications
Thermo Fisher Scientific has announced that it has become a founding sponsor of Momentum Labs in Alachua, Florida, US. The …
Indonesia begins hearing class-action lawsuit after children’s deaths from cough syrup
January 17, 2023 Medical Communications
An Indonesian court has begun proceedings to hear a class-action lawsuit against health and finance ministries, the drugs regulator and …
Boehringer Ingelheim and 3T Biosciences form $268m partnership to develop next-generation cancer immunotherapies
January 16, 2023 Medical Communications
Germany-based Boehringer Ingelheim and US company 3T Biosciences have entered into a strategic collaboration and licensing agreement to research and …
Eli Lilly and AbbVie leave UK VPAS; blow to UK pharma industry
January 16, 2023 Medical Communications
Eli Lilly and AbbVie have announced their departure from the voluntary scheme for branded medicines pricing and access (VPAS), causing …
Pfizer’s COVID-19 vaccine under FDA’s examination following new research into adverse side effects
January 13, 2023 Medical Communications
The FDA, along with Taiwanese medical institutions, have been evaluating Pfizer’s mRNA COVID-19 vaccine, questioning the CDC’s omission of known …
Diabeloop and EOFlow team up to develop an automated insulin device
January 13, 2023 Medical Communications
Diabeloop, a medical device company focused on automated diabetes treatment solutions, and South Korea-based EOFlow have joined forces to offer …
BD showcase new-generation robotic track system for microbiology labs
January 12, 2023 Medical Communications
US-based Becton, Dickinson and Company (BD) has revealed new-generation robotic track system for its BD Kiestra microbiology laboratory solution which …
FDA clears first ACL reconstruction device for use in paediatric patients
January 11, 2023 Medical Communications
The FDA has cleared the ACL TightRope® II implant to treat torn knee ligaments in children and adolescents. The implant …
BioNTech acquires AI company InstaDeep for £562m
January 11, 2023 Medical Communications
Germany-based BioNTech has acquired UK AI start up InstaDeep for £562m after a multi-year partnership. The acquisition is part of …
Insilico Medicine shares positive topline results of phase 1 trial of AI-designed drug for AI-discovered target
January 10, 2023 Medical Communications
Clinical stage AI-driven drug R&D company, Insilico Medicine, has announced positive topline results from its phase 1 trial assessing the …
FDA issues Emergency Use Authorisation for BD and CerTest Biotec’s Monkeypox PCR test
January 10, 2023 Medical Communications
US medical technology company BD and Spanish biotechnology company CerTest Biotec have joined forces to develop a real-time Monkeypox test …
NHS to offer artificial pancreas to type 1 diabetes patients
January 10, 2023 Medical Communications
The NHS will soon be offering an artificial pancreas to more than 100,000 people with type 1 diabetes across England …
BioNTech and UK Government announce strategic partnership to provide mRNA cancer immunotherapies
January 6, 2023 Medical Communications
German biotech company BioNTech and the UK Government have signed a Memorandum of Understanding (MoU) which will accelerate clinical trials …
Latest content
Acumentis CEO Herspiegel steps down as Burden assumes role
October 27, 2026
October 26, 2026
